Streetbeat News

Stock Prices

PRAX

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) will present data from its epilepsy programs at the ILAE 15th European Epilepsy Congress in 2024, showcasing its focus on CNS disorders.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 12:02 pm

NVDA

Nvidia and Bitcoin experienced significant price drops amid a market downturn, with Nvidia falling 9.53% and Bitcoin dropping over 4%. Both assets show increased implied volatility, suggesting potential for further price swings.

Portfolio Pulse from Aniket Verma

September 04, 2024 | 12:01 pm

NDAQ

In the past three months, 7 analysts have rated Nasdaq (NDAQ) with varying perspectives. The average 12-month price target has increased by 11.24% to $77.71. Analysts have raised their ratings and price targets, reflecting positive sentiment. Despite strong revenue growth, Nasdaq faces challenges with profitability and financial risk.

Portfolio Pulse from Benzinga Insights

September 04, 2024 | 12:01 pm

BYD

Boyd Gaming (NYSE:BYD) has been analyzed by 4 analysts over the past three months, showing a range of perspectives from somewhat bullish to indifferent. The average 12-month price target is $68.75, with a high of $74.00 and a low of $66.00. Recent analyst actions include a mix of raised and lowered ratings and price targets. Boyd Gaming shows strong financial performance with a solid revenue growth rate, high net margin, and effective debt management.

Portfolio Pulse from Benzinga Insights

September 04, 2024 | 12:00 pm

UHS

Analysts have provided a range of ratings for Universal Health Services (NYSE:UHS) over the past quarter, with a mix of bullish and bearish sentiments. The average 12-month price target has increased by 11% to $215.0. UHS has shown strong financial performance with a 10.13% revenue growth rate, a net margin of 7.4%, and a balanced debt-to-equity ratio of 0.77.

Portfolio Pulse from Benzinga Insights

September 04, 2024 | 12:00 pm

APH

In the past three months, six analysts have provided ratings for Amphenol (NYSE:APH), ranging from bullish to bearish. The average 12-month price target is $72.83, slightly down from $73.50. Analysts have adjusted their ratings and price targets, reflecting their views on Amphenol's market position. The company shows strong financial performance with high revenue growth and profitability, but faces challenges in debt management.

Portfolio Pulse from Benzinga Insights

September 04, 2024 | 12:00 pm

SEE

Sealed Air (NYSE:SEE) has received mixed analyst ratings over the past three months, with a range of bullish to bearish perspectives. The average 12-month price target has declined by 4.3% to $40.33. Analysts have adjusted their ratings and price targets in response to market dynamics and company performance. Sealed Air faces challenges in revenue growth and profitability, but shows strong return on equity. The company's high debt-to-equity ratio raises concerns about financial leverage.

Portfolio Pulse from Benzinga Insights

September 04, 2024 | 12:00 pm

CRMT

America's Car-Mart shares declined following a year-over-year decrease in Q1 EPS results.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 11:56 am

DUST

NUGT

The article discusses trading opportunities in Direxion's leveraged ETFs, NUGT and DUST, amid economic debates and gold's safe-haven status. Goldman Sachs' positive outlook on gold and potential Fed rate cuts could influence these ETFs. NUGT has seen recent losses, while DUST has gained.

Portfolio Pulse from Joshenomoto@benzinga.com

September 04, 2024 | 11:55 am

CIEN

Ciena Corp reported a Q3 revenue decline of 11.8% to $942.3 million, beating estimates. EPS also surpassed expectations. Despite a decline in operating margin, the company showed growth in cloud services. CFO James Moylan announced his retirement, effective in 2025.

Portfolio Pulse from Anusuya Lahiri

September 04, 2024 | 11:54 am